Ipca Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 1,827.94 | 1,581.25 | 1,525.72 |
| Operating Expense | 1,408.83 | 1,212.62 | 1,312.60 |
| Net Profit | 244.12 | 204.13 | 64.76 |
| Net Profit Margin | 13.35 | 12.91 | 4.24 |
| Earning Per Share | 9.62 | 8.05 | 2.55 |
| EBIDTA | 418.52 | 365.87 | 212.49 |
| Effective Tax Rate | 22.55 | 21.97 | 29.05 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 1827.94 |
| Operating Expense | 1408.83 |
| Net Profit | 244.12 |
| Net Profit Margin | 13.35 |
| Earning Per Share | 9.62 |
| EBIDTA | 418.52 |
| Effective Tax Rate | 22.55 |
Invest in Ipca Laboratories Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 6,166.46 | 5,814.62 | 5,438.30 |
| Operating Expenses Annual | 4,955.08 | 4,902.77 | 4,200.22 |
| Operating Profit Annual | 1,189.31 | 1,023.04 | 1,291 |
| Interest Annual | 120.67 | 43.92 | 7.24 |
| Depreciation | 238.08 | 219.13 | 201.03 |
| Net Profit Annual | 530.41 | 505.70 | 860.37 |
| Tax Annual | 291.75 | 244.79 | 213.74 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 6,166.46 |
| Operating Expenses Annual | 4,955.08 |
| Operating Profit Annual | 1,189.31 |
| Interest Annual | 120.67 |
| Depreciation | 238.08 |
| Net Profit Annual | 530.41 |
| Tax Annual | 291.75 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 1,504.83 | 945.77 | 499.86 |
| Cash Flow from Operations | 830.51 | 762.29 | 831.72 |
| Cash Flow from Investing | -1,355.18 | -709.61 | -811.85 |
| Cash Flow from Financing | -464.88 | 506.38 | 426.04 |
| Cash Flow at the End | 515.28 | 1,504.83 | 945.77 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 1,504.83 |
| Cash Flow from Operations | 830.51 |
| Cash Flow from Investing | -1,355.18 |
| Cash Flow from Financing | -464.88 |
| Cash Flow at the End | 515.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 21.08 | 17.64 | 23.80 |
| PBIT Margin (%) | 17.08 | 13.70 | 19.94 |
| PBT Margin (%) | 16.94 | 13.40 | 18.02 |
| Net PROFIT Margin (%) | 8.60 | 8.70 | 15.82 |
| Return On Networth / Equity (%) | 9.81 | 8.91 | 16.82 |
| Return On Networth /Employed (%) | 14.12 | 11.67 | 19.15 |
| Return On Assets (%) | 7.14 | 7.39 | 15.19 |
| Total Debt / Equity (X) | 0.21 | 0.20 | 0.10 |
| Asset Turnover Ratio (%) | 0.83 | 0.85 | 0.96 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 21.08 |
| PBIT Margin (%) | 17.08 |
| PBT Margin (%) | 16.94 |
| Net PROFIT Margin (%) | 8.60 |
| Return On Networth / Equity (%) | 9.81 |
| Return On Networth /Employed (%) | 14.12 |
| Return On Assets (%) | 7.14 |
| Total Debt / Equity (X) | 0.21 |
| Asset Turnover Ratio (%) | 0.83 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 2,533.17 | 2,487.37 | 2,156.87 |
| Total Current Assets Annual | 3,509.89 | 4,875.15 | 4,224.46 |
| Non Current Assets Annual | 5,149.38 | 3,571.82 | 3,203.52 |
| Total Shareholders Funds Annual | 6,348.71 | 5,877.30 | 5,475.76 |
| Total Assets Annual | 8,659.27 | 8,446.97 | 7,438.44 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 2,533.17 |
| Total Current Assets Annual | 3,509.89 |
| Non Current Assets Annual | 5,149.38 |
| Total Shareholders Funds Annual | 6,348.71 |
| Total Assets Annual | 8,659.27 |
EPS (INR)
Expected
9.05
Reported
9.05
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
